Contract V797D50564
Mayne Pharma Commercial Llc · Department Of Veterans Affairs · March 2, 2016
Mayne Pharma Commercial Llc was awarded a federal contract by Department Of Veterans Affairs on March 2, 2016 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 160 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on July 10, 2025. If all options are exercised, the contract could reach $5.00 million.
Contract details
- PIID
- V797D50564
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- March 2, 2016
- Latest action
- July 10, 2025
Description
CONTRACT CANCELLATION
Modification timeline
-
July 10, 2025Mod P00180$0
-
June 17, 2025Mod P00179ADDITION$0
-
May 20, 2025Mod P00178SHORT TERM EXTENSION$0
-
March 10, 2025Mod P00177NDC CHANGE$0
-
March 4, 2025Mod P00176PUBLIC LAW LIFECYCLE PERMANENT$0
-
February 20, 2025Mod P00173SHORT TERM EXTENSION$0
-
February 20, 2025Mod P00174NDC CHANGE$0
-
February 20, 2025Mod P00175DELETION$0
-
January 8, 2025Mod P00172DELETION$0
-
December 5, 2024Mod P00171PUBLIC LAW 2025 PRICING UPDATES$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract V797D50564?
Contract V797D50564 is a federal contract awarded to Mayne Pharma Commercial Llc by Department Of Veterans Affairs on March 2, 2016 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 160 times since the base award.
Who won contract V797D50564?
Mayne Pharma Commercial Llc won contract V797D50564 from Department Of Veterans Affairs.
How much is contract V797D50564 worth?
Contract V797D50564 has obligated $0 to date but carries a potential ceiling of $5.00 million if fully funded and all options are exercised.